Frontier IP, a specialist in commercialising intellectual property is working in partnership to create a novel innovation hub ...

AstraZeneca has signed a research agreement worth more than US$5 billion with Chinese drugmaker CSPC Pharmaceutical Group, ...

“Straight out of the blocks,” he says, “Cambridge Wide Open Week has been a whirlwind of inspiring pitches, thought-provoking ...

Multinationals on China: China has set a GDP growth target of around 5% for 2025. How do you view this target and China’s ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

The Cambridge Independent Business Awards 2025 are now open for entry. Following the success of our inaugural awards last year, we are delighted to announce that the search is now on for the best in ...

But private sector companies like AstraZeneca are pushing forward with major investments in life sciences research and manufacturing. The Cambridge, U.K.-based pharmaceutical giant on Monday ...

While the Cambridge-based company is still waiting ... as trade tensions shift the global focus to the US – AstraZeneca’s biggest market. It came a day after Beijing touted itself as a meditech hub ...

As a critical hub for medical research and innovation ... WalkBek Consulting and Regulogix Consulting. Organised by HBA Cambridge and sponsored by AstraZeneca, the launch event was hosted at AZ’s ...

Oxford and Cambridge, which are renowned for their contributions to science, technology, and innovation. The area is also home to established tech companies like Microsoft, Amazon, and AstraZeneca.

with the manufacturing and logistics hub of Milton Keynes in between. “The Oxford-Cambridge Arc is already an engine of prosperity, but we can go even further. We are determined to unleash ...